Search Results for “mental health” – Page 17 – media

Rise in China’s Global Pharma Market up to $175 billion by 2022 – Market Prediction

Though the US stands first in the race in terms of sales and growth, it is highly believed that China would reach the peak in the pharma market by 2022. At present, since there has been a decrease in public health funding, there has been a slight fall in pharmerging countries like Brazil, Russia, India and China (BRIC). But it is believed that the condition of these pharmerging countries will improve in the next five years [1].
- Source: Ddu
- 822
- May 24, 2018
China Market Views pharmaceutical drugs
Computerized ADHD – A Novel Diagnostic Tool

A new clinical trial executed under lead investigator, Professor Chris Hollis from the University of Nottingham in the UK, revealed that by adding a computerized test of attention and activity (QbTest) to standard subjective assessments, the clinicians could easily make a diagnostic decision on ADHD, with proper accuracy.
- Source: Ddu
- 544
- May 23, 2018
ADHD Researches
New wearable brain scanner allows patients to move freely for the first time

A new generation of brain scanner, that can be worn like a helmet allowing patients to move naturally whilst being scanned, has been developed by researchers at the Sir Peter Mansfield Imaging Centre, University of Nottingham and the Wellcome Centre for Human Neuroimaging, UCL. It is part of a five-year Wellcome funded project which has the potential to revolutionize the world of human brain imaging.
- Source: Medical Xpress
- 558
- March 22, 2018
brain medtech Researches
Flu breath– sick people can spread the flu virus just by breathing

The flu is a bit of a stealth microbe. Infected people may shed significant amounts of flu virus simply by breathing, scientists have discovered.
- Source: cbc
- 584
- February 23, 2018
flu Researches
EKGs May Determine Major Depression or Bipolar Disorder

A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder.
- Source: bphope
- 625
- February 14, 2018
bipolar disorder Depression Researches
Short-term exposure to low levels of air pollution linked with premature death among US seniors

Short-term exposures to fine particulate air pollution and ozone—even at levels well below current national safety standards—were linked to higher risk of premature death among the elderly in the U.S. according to a new study from Harvard T.H. Chan School of Public Health.
- Source: medicalxpress
- 400
- December 27, 2017
premature death Researches
The Holiday Season Can Bring New Obstacles For Addicts, Here’s How to Help

If left unidentified, a compulsive behavior can turn into a new addiction. Even if your substance recovery is strong, you can’t ignore the fact that other addictions can come forward.
- Source: msn
- 371
- December 25, 2017
Holiday Season Researches
How can you cope with seasonal affective disorder?

Seasonal affective disorder (SAD) is a type of depression that comes and goes with the four seasons, typically manifesting during the cold autumn and winter months, when the days are shorter, darker, and chillier.
- Source: medicalnewstoday
- 404
- November 27, 2017
Market Views SAD Seasonal affective disorder
Allegoric Receives FDA Approval For Use of VRAYLAR™ (cariprazine) in the Maintenance Treatment of Schizophrenia

Allergan plc (NYSE: AGN) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance treatment of adults with schizophrenia. VRAYLAR is also approved in the U.S. in adults for the acute treatment of schizophrenia and acute treatment of manic or mixed episodes of bipolar I disorder.
- Source: Allergan
- 474
- November 24, 2017
bipolar I disorder FDA schizophrenia VRAYLAR™
UNAIDS announces nearly 21 million people living with HIV now on treatment

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy. By June 2017, around 20.9 million people had access to the life-saving medicines. Such a dramatic scale-up could not have happened without the courage and determination of people living with HIV demanding and claiming their rights, backed up by steady, strong leadership and financial commitment.
- Source: reliefweb
- 446
- November 21, 2017
antiretroviral HIV UNAIDS

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.